Skip to content

Clinical trials

Completed Leukemia, Promyelocytic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Promyelocytic, Acute Status: Completed Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20011
20022
20031
20044
20055
20066
20079
20094
20103
20113
20122
20133
20141
20151
20162
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)17
Memorial Sloan Kettering Cancer Center5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
Case Comprehensive Cancer Center4
Children's Oncology Group4
Gruppo Italiano Malattie EMatologiche dell'Adulto3
M.D. Anderson Cancer Center3
PETHEMA Foundation3
University of Maryland, Baltimore3
Eastern Cooperative Oncology Group2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Promyelocytic, Acute74
Leukemia, Myeloid, Acute46
Leukemia, Myelomonocytic, Acute31
Leukemia30
Precursor Cell Lymphoblastic Leukemia-Lymphoma26
Leukemia, Erythroblastic, Acute22
Leukemia, Megakaryoblastic, Acute22
Leukemia, Monocytic, Acute22
Blast Crisis21
Congenital Abnormalities18

Trials

Showing 76 to 74 of 74. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.